ASXDate of AGM & Closing Date for Director Nominations
other announcement
Island Pharmaceuticals (ILA) News
Latest articles and price-sensitive announcements with AI sentiment classification.
KalkineIsland Pharmaceuticals (ASX:ILA): What Does the Share Move Signal?
Highlights Island Pharmaceuticals has sought quotation of additional shares, putting capital structure and equity administration back in view. The company remains an early-stage healthcare developer, making clinical execution, regulatory progress and funding discipline central to the story. The next meaningful evidence will come from how new equity supports antiviral development milestones rather than from the quotation process alone. Island Pharmaceuticals (ASX:ILA) is back in view after see...
Quick hits: Swimmer spurns Love Island offer, dictator's grandson's vow
A Scottish swimmer rejects an approach to appear on a dating reality show and Idi Amin's grandson reveals his royal plans. Here are the quick hits from day six of the Commonwealth Games.
StockheadBiocurious: Post Germageddon, Island Pharma will keep the US ticking over
Island Pharmaceuticals is confident that its acquired drug Galidesivir can make a difference to the Ebola outbreak sweeping central Africa. ... Read More The post Biocurious: Post Germageddon, Island Pharma will keep the US ticking over appeared first on Stockhead.
Investor Presentation - TechKnow Invest Roadshow
other announcement
Could an Outbreak Deployment Reshape Island Pharma?
Highlights Island Pharmaceuticals has moved to deploy its antiviral candidate to help treat patients caught in an Ebola outbreak in Uganda. The humanitarian deployment offers a rare real-world setting to observe the compound outside a formal trial. The news lands amid a broad rebound in Australian healthcare shares from recent lows. Island Pharmaceuticals (ASX:ILA), the Sydney-based clinical-stage developer focused on repurposing antiviral compounds against dangerous ...
Texas Biomed SOW accelerates pivotal FDA pathway
other announcement
Notification regarding unquoted securities - ILA
other announcement
Long Shortz with Island Pharmaceuticals: Ebola, Marburg and Dengue clinical programs advance
Managing director unpacks series of major milestones achieved across Galidesivir, Marburg and dengue clinical programs. ... Read More The post Long Shortz with Island Pharmaceuticals: Ebola, Marburg and Dengue clinical programs advance appeared first on Stockhead.
Island Pharma gets green light to use Galidesivir in Ebola outbreak
If Galidesivir demonstrates efficacy, the program’s result may support future government procurement, biodefence stockpiling and broader commercialisation opportunities. ... Read More The post Island Pharma gets green light to use Galidesivir in Ebola outbreak appeared first on Stockhead.
Google NewsWhy Island Pharmaceuticals (ASX:ILA) Shares Are Trading Higher On Tuesday? - Kalkine
Why Island Pharmaceuticals (ASX:ILA) Shares Are Trading Higher On Tuesday? Kalkine
Galidesivir approved for treatment use in in Ebola epidemic
other announcement
Island Pharmaceuticals (ASX:ILA) Falls as Investors Reassess Clinical-Stage Biotech Risks - Kalkine
Island Pharmaceuticals (ASX:ILA) Falls as Investors Reassess Clinical-Stage Biotech Risks Kalkine
Island Pharmaceuticals (ASX:ILA) Advances IP Strategy with Singapore Patent - Kalkine
Island Pharmaceuticals (ASX:ILA) Advances IP Strategy with Singapore Patent Kalkine
Singapore Patent Expands Island's ISLA 101 Viral Protection
other announcement
Superbikes move leaves Phillip Island community in limbo
The Phillip Island community is coming to terms with the loss of another major sporting event with South Australia claiming the rights to Australia's Superbike World Championship race from 2028.
FDA Grants Orphan Designation for Galidesivir in Marburg
other announcement
Small Caps
Island expands its US biodefence collaboration for heavy-hitting virus study
Island Pharmaceuticals has expanded its US army collaboration, to further its groundbreaking candidate Galidesivir for treating Marburg Virus Disease. ... Read More The post Island expands its US biodefence collaboration for heavy-hitting virus study appeared first on Stockhead.
Island Secures USAMRIID Support for Galidesivir Study
other announcement
Island Advances Galidesivir GMP Manufacturing for Biodefence
other announcement
Leadership Shift Sparks Fresh Focus at Middle Island
Highlights Leadership transition underway at Middle Island Resources Executive Chairman takes charge during transition phase Serbian mineral assets remain central to company strategy Middle Island Resources enters a new leadership phase as the company restructures executive responsibilities while maintaining focus on exploration activities and long-term development plans across its mineral assets. Middle Island Resources (ASX:MDI) has entered a new chapter following a significant execut...
Island Adds Biodefence Leader as Filovirus Risks Escalate
other announcement
Island Pharmaceuticals Builds Momentum in Antiviral Space
Highlights Island Pharmaceuticals advances antiviral research Debt-free position supports long-term focus Analysts anticipate a shift toward profitability Island Pharmaceuticals is drawing investor attention as its antiviral development pipeline progresses alongside a debt-free balance sheet and growing expectations around future profitability. Island Pharmaceuticals Limited (ASX:ILA) is increasingly gaining attention across the Australian biotechnology sector as investors closely watch...
Island Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focusIsland Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focus - Kalkine
Island Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focusIsland Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focus Kalkine
Break it Down: Island expands US biodefence engagement ahead of Galidesivir studies
Island Pharmaceuticals appoints a senior security advisor and advances preparation for its Galidesivir clinical trial. ... Read More The post Break it Down: Island expands US biodefence engagement ahead of Galidesivir studies appeared first on Stockhead.
Island Bolsters US Biodefence Readiness Ahead of Trials
other announcement
Health Check: Island Pharmaceuticals shares soar on spreading Ebola outbreak
Amid a spreading Ebola virus outbreak in Africa, Island Pharmaceuticals is pursuing an elusive cure. Investors are taking notice. ... Read More The post Health Check: Island Pharmaceuticals shares soar on spreading Ebola outbreak appeared first on Stockhead.
Invaded: The billionaire who bought Epstein Island is under siege from trespassers
The latest reports from “Little St. Jeff’s,” the notorious Caribbean hideaway of Jeffrey Epstein, are startling.
Island Pharma Share Move: What It Means Now
Highlights Fresh share quotation signals capital structure expansion Market activity reflects evolving sentiment in healthcare space Liquidity changes remain key focus for market participants Island Pharmaceuticals expands its share base through ASX quotation, highlighting capital flexibility and evolving liquidity dynamics within Australia’s healthcare-focused market environment. Australia’s short selling sector often reveals how sentiment shifts beneath the surface of the ASX 20...
Antiviral pipeline expansion through strategic collaboration
other announcement
US Government collaboration for Galidesivir development
other announcement
$9m placement to advance US biodefence opportunity
capital_raise announcement